Clinical practice guideline for activated phosphatidyl inositol 3-kinase-delta syndrome in Japan

Clinical practice guideline for activated phosphatidyl inositol 3-kinase-delta syndrome in Japan

AbstractActivated phosphatidyl inositol 3-kinase-delta syndrome (APDS) due to gain-of-function variant in the class IA PI3K catalytic subunit p110δ (responsible gene: PIK3CD) was described in 2013. The disease is characterized by recurrent airway infections and bronchiectasis. It is associated with...

Full description

Bibliographic Details
Main Authors: Kunihiko Moriya, Kanako Mitsui-Sekinaka, Yujin Sekinaka, Akifumi Endo, Hirokazu Kanegane, Tomohiro Morio, Kohsuke Imai, Shigeaki Nonoyama
Format: Article
Language:English
Published: Taylor & Francis Group 2023-10-01
Series:Immunological Medicine
Subjects:
APDS
hyper-IgM syndrome
immune dysregulations
diagnostic flow chart
Online Access:https://www.tandfonline.com/doi/10.1080/25785826.2023.2210366

Internet

https://www.tandfonline.com/doi/10.1080/25785826.2023.2210366

Similar Items